UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 5,586	$ 5,556
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	301	311
Amortization	1,259	1,376
Provision for (recovery of) losses on accounts receivable	(9)	6
(Gain) loss on disposal of assets	1	4
Deferred income taxes	(213)	(282)
Stock-based compensation expense	44	24
Changes in operating assets and liabilities:
Accounts receivable	(828)	(1,016)
Accrued interest and other receivables	(81)	(31)
Inventories	218	(472)
Prepaid expenses and other current assets	104	118
Accounts payable	5	91
Accrued expenses	(654)	75
Total adjustments	147	204
Net cash provided by operating activities	5,733	5,760
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(109)	(836)
Capital expenditures for intangible assets	(7)	0
Net cash provided by (used in) investing activities	(116)	(836)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	245	271
Common stock purchased and retired	(215)	(818)
Payment of taxes for exchange of stock options	(42)	0
Tax benefit attributable to exercise of stock options	107	120
Repayment of notes payable	(4,778)	(2,035)
Payment of dividends	(957)	(938)
Net cash provided by (used in) financing activities	(5,640)	(3,400)
Effect of exchange rate changes on cash	(82)	20
Net increase (decrease) in cash and cash equivalents	(105)	1,544
Cash at beginning of period	19,274	14,395
Cash at end of period	19,169	15,939
Cash paid during the period for income taxes	2,781	1,551
Cash paid during the period for interest	$ 65	$ 167